Target intelligence / Profile preview

Cyclin A1 (CCNA1)

Target: CCNA1
Molecular classification: Cyclin, Cell Cycle Regulator

Overview

Cyclin A1 (CCNA1) is a key regulator of cell cycle progression, particularly in meiosis. It forms complexes with CDK2 and CDC2 (CDK1), influencing S phase and G2/M transition, respectively. Aberrant expression is associated with certain cancers, including myeloid leukemia and testicular cancer.

Other names: Cyclin-A1CCNA1

Biological functions

Cell cycle regulationMeiosis controlCheckpoint controlKinase activity regulation

Disease associations

CancerMyeloid leukemiaTesticular cancer

Beyond the preview

Go deeper on Cyclin A1 (CCNA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin A1 (CCNA1).

Explore the full profile